Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLsl Prop Regulatory News (LSL)

Share Price Information for Lsl Prop (LSL)

Share Price is delayed by 15 minutes
Get Live Data
211.00    -3.00 (-1.40%)
Bid:
212.00
Ask:
216.00
Spread: 4.00 (1.887%)
Market Cap: £208.98m
LSL Live PriceLast checked at - London Stock Exchange

Intraday Lsl Prop Share Chart

Form 8.3 - LSL Property

25 Feb 2020 12:13

Premier Miton Group Plc - Form 8.3 - LSL Property

Premier Miton Group Plc - Form 8.3 - LSL Property

PR Newswire

London, February 25

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: PREMIER MITON GROUP PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LSL PROPERTY SERVICES PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 24/02/2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:2,681,4132.57
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:2,681,4132.57

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:25/02/2020
Contact name:Georgina Thomas
Telephone number*:0203 714 1478

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
4th Jun 20267:00 amRNSTransaction in own Shares and Total Voting Rights
2nd Jun 20267:00 amRNSTransaction in own Shares and Total Voting Rights
1st Jun 20267:00 amRNSTransaction in own Shares and Total Voting Rights
29th May 20261:00 pmRNSDirector / PDMR Shareholding
28th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
26th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
22nd May 20263:12 pmRNSNotification of Major Holdings
22nd May 202610:00 amRNSDirectors’ Share Purchases
21st May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
20th May 202612:30 pmRNSNotification of Major Holdings
19th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
18th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
15th May 20264:00 pmRNSResult of Annual General Meeting
15th May 20267:00 amRNSAGM Trading Update
14th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
12th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
11th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
7th May 20262:00 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
6th May 20264:34 pmRNSDirector/ PDMR Dealing
5th May 20267:00 amRNSTransaction in own Shares and Total Voting Rights
30th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
28th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
27th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
23rd Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
21st Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
20th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
16th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
14th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
13th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
9th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
8th Apr 20265:00 pmRNSDirector/PDMR Shareholding
7th Apr 202611:30 amRNSNotification of Major Holdings
7th Apr 202610:30 amRNSNotice of the 2026 Annual General Meeting
7th Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
1st Apr 20267:00 amRNSTransaction in own Shares and Total Voting Rights
30th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
26th Mar 20264:50 pmRNSPublication of Annual Report and Accounts 2025
26th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
24th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
23rd Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
19th Mar 20267:00 amRNSFull Year Results
19th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
17th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
17th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
16th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
16th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
12th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
10th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights
9th Mar 20267:00 amRNSTransaction in own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.